I'm following the compassionate use threads, as most of us here are, but I do wonder why the concern? After all, compassionate use is by IV, usually after patients are really sick or soon getting there, and subject to the same issues that caused the failure of the B test for covid. It would be a lot different if we were dealing with compassionate use of an injection, even a pill, with the complexities that implies, an inhalant or some other method of treatment that could address patients earlier in the course of covid, before they are in a hospital bed with an IV line already run. Leo chose to leave the IV treatment mode as the main treatment mode, having no lab to develop alternatives nor money allocated to other labs to develop alternatives; we are left with trying to make good coffee with coffee grounds (just addressing B for covid, but the analogy extends further, I am afraid). There are remaining anti-viral, IBD, OM and even anti-biotic avenues of potential success, though some have declined in potential with recent competition, for future success, but hoping for compassionate use options just does not seem like a good thing to spend time wishing for. I left off kevetrin as a future option as I have no idea or hunch about what the future may bring. Does anyone here?
News 
Market Data 
Discover 
